Medplus Health Services Ltd Share Price – NSE /  BSE

Retail, Small Cap

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Medplus Health Services rose 25.98% to Rs 57.81 crore in the quarter ended December 2025 as against Rs 45.89 crore during the previous quarter ended December 2024. Sales rose 15.67% to Rs 1806.12 crore in the quarter ended December 2025 as against Rs 1561.45 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 30 January 2026.

Powered by Capital Market - Live News

Profit before tax (PBT) climbed 44.3% to Rs 68.94 crore in Q2 FY26.

EBITDA stood at Rs 166.3 crore in Q2 FY26, registering the growth of 22.28% compared with Rs 136 crore posted in corresponding quarter last year. EBITDA margin improved to 9.9% in Q2 FY26 as against 8.6% in Q2 FY25.

On the segmental front, revenue from the retail segment rose 6.34% YoY to Rs 1,645.64 crore, while revenue from diagnostic services grew 17.45% YoY to Rs 33.25 crore in Q2 FY26.

For the first half of FY26, the company?s consolidated net profit surged 84.3% to Rs 97.86 crore on 5.1% increase in revenue from operations to Rs 3,221.96 crore in H1 FY26 over H1 FY25.

MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers.

Powered by Capital Market - Live News